COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics publie son rapport d’activité du troisième trimestre 2018
07/11/2018
Information réglementée Résultats positifs d’efficacité et de sécurité de l’étude de Phase I/II avec ALLOB dans les fractures avec retard de consolidation, encourageant la poursuite du développement clinique Mise en [...]
XORTX Announces Appointment of CFO
07/11/2018
CALGARY, Alberta, Nov. 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results
07/11/2018
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products, today reported [...]
Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018
06/11/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it plans to release third [...]
Akorn Provides Third Quarter 2018 Results
06/11/2018
LAKE FOREST, Ill., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the third quarter of 2018. Business [...]
National Research Corporation Announces Third Quarter 2018 Results
06/11/2018
LINCOLN, Neb., Nov. 06, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the third quarter of 2018. Net New Sales of $6.2 million Revenue up 4% to $30 million Operating [...]
Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2018 Financial Results and Business Updates
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders
06/11/2018
MINNEAPOLIS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX-V:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company, today announced the voting results from its Annual General and Special [...]
Momenta Pharmaceuticals Announces Global Settlement with AbbVie to Enable Commercialization of M923, a Proposed Biosimilar to HUMIRA® (adalimumab)
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced that it has executed agreements with AbbVie Inc., providing license rights for the global launch of M923, [...]
Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018
– Company to Provide ILLUMINATE 204 Data Update in the First Half of December 2018 – – Cash runway into first quarter of 2020 – EXTON, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a [...]
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
06/11/2018
SOUTH SAN FRANCISCO, Calif. , Nov. 06, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that the Company will participate in the following investor conferences in November and [...]
Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018
06/11/2018
BOSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
R1 Announces Collaborative Partnership with Robotic Process Automation Technology Leader Automation Anywhere to Enhance Revenue Cycle Management
06/11/2018
New relationship builds upon R1’s existing automation technology to drive demonstrable results CHICAGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle [...]
Aduro to Host and Webcast an Investor Event to Review Data Presented at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
06/11/2018
BERKELEY, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the company will host and webcast an investor event on Friday, November 9, 2018 at 6:30 p.m. Eastern Time in [...]
The Cooper Companies Announces Release Date for Fourth Quarter and Full Year 2018
06/11/2018
PLEASANTON, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release fourth quarter and full year 2018 financial results on Thursday, December 6, 2018, at 4:15 PM [...]
Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue
06/11/2018
Total revenue of $103.0 million, a 28% increase over 2017 Net product sales of $100.2 million, a 28% increase over 2017 Operating earnings of $37.5 million, a 68% increase over 2017 Diluted earnings per share (GAAP) of [...]
Inspire Medical Systems, Inc. Announces Third Quarter 2018 Financial Results and Updates 2018 Outlook
06/11/2018
MINNEAPOLIS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Capital Senior Living Corporation Reports Third Quarter 2018 Results
06/11/2018
DALLAS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE:CSU), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform
06/11/2018
Initial Limited Market Release Shipments to Commence Immediately IRVINE, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced FDA clearance for the company’s latest software [...]

Pages